Literature DB >> 27422251

Sepsis in cirrhosis: emerging concepts in pathogenesis, diagnosis and management.

Cyriac Abby Philips1, Shiv Kumar Sarin2.   

Abstract

Infections and sepsis are more common in cirrhotic than in the general population and constitute the commonest cause of sudden worsening and death. The diagnosis of systemic inflammatory syndrome and sepsis are challenging in cirrhotics due to an underlying a state of hyperdynamic circulation. Further, poor nutritional and bone marrow reserves lead to modest host immune response, the so called immunoparalysis state and the outcome of antibiotic therapy is suboptimal. In this review, a comprehensive description of current and emerging concepts in the pathogenesis and diagnosis of sepsis with importance to current and novel biomarkers for diagnosis of sepsis in cirrhosis is presented. Furthermore, novel treatment options and preventive strategies are discussed to improve the overall survival.

Entities:  

Keywords:  Antibiotics; Cirrhosis; Cytokines; Immunoparalysis; Infection; Inflammatory response; Portal hypertension; Sepsis; Septic shock

Mesh:

Substances:

Year:  2016        PMID: 27422251     DOI: 10.1007/s12072-016-9753-2

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  44 in total

1.  Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis.

Authors:  Yasunori Yaegashi; Kamon Shirakawa; Nobuhiro Sato; Yasushi Suzuki; Masahiro Kojika; Satoko Imai; Gaku Takahashi; Michiko Miyata; Shoji Furusako; Shigeatsu Endo
Journal:  J Infect Chemother       Date:  2005-10       Impact factor: 2.211

2.  Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis.

Authors:  Pablo Bellot; Juan Carlos García-Pagán; Rubén Francés; Juan G Abraldes; Miguel Navasa; Miguel Pérez-Mateo; José Such; Jaime Bosch
Journal:  Hepatology       Date:  2010-10-26       Impact factor: 17.425

3.  Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patients.

Authors:  Caroline Guignant; Nicolas Voirin; Fabienne Venet; Françoise Poitevin; Christophe Malcus; Julien Bohé; Alain Lepape; Guillaume Monneret
Journal:  Intensive Care Med       Date:  2009-08-07       Impact factor: 17.440

4.  Dose-dependent effect of anti-CTLA-4 on survival in sepsis.

Authors:  Shigeaki Inoue; Lulong Bo; Jinjun Bian; Jacqueline Unsinger; Katherine Chang; Richard S Hotchkiss
Journal:  Shock       Date:  2011-07       Impact factor: 3.454

Review 5.  Antibiotic de-escalation in the ICU: how is it best done?

Authors:  Jose Garnacho-Montero; Ana Escoresca-Ortega; Esperanza Fernández-Delgado
Journal:  Curr Opin Infect Dis       Date:  2015-04       Impact factor: 4.915

Review 6.  The new normal: immunomodulatory agents against sepsis immune suppression.

Authors:  Noelle A Hutchins; Jacqueline Unsinger; Richard S Hotchkiss; Alfred Ayala
Journal:  Trends Mol Med       Date:  2014-01-30       Impact factor: 11.951

7.  Neutrophil secretion products regulate anti-bacterial activity in monocytes and macrophages.

Authors:  O Soehnlein; E Kenne; P Rotzius; E E Eriksson; L Lindbom
Journal:  Clin Exp Immunol       Date:  2007-12-07       Impact factor: 4.330

8.  Role of systemic inflammation in cirrhosis: From pathogenesis to prognosis.

Authors:  Melisa Dirchwolf; Andrés Eduardo Ruf
Journal:  World J Hepatol       Date:  2015-08-08

9.  Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK.

Authors:  Christine Bernsmeier; Oltin T Pop; Arjuna Singanayagam; Evangelos Triantafyllou; Vishal C Patel; Christopher J Weston; Stuart Curbishley; Fouzia Sadiq; Nikhil Vergis; Wafa Khamri; William Bernal; Georg Auzinger; Michael Heneghan; Yun Ma; Wayel Jassem; Nigel D Heaton; David H Adams; Alberto Quaglia; Mark R Thursz; Julia Wendon; Charalambos G Antoniades
Journal:  Gastroenterology       Date:  2014-12-03       Impact factor: 22.682

10.  Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis.

Authors:  Yaseen M Arabi; Saqib I Dara; Ziad Memish; Abdulmajeed Al Abdulkareem; Hani M Tamim; Nehad Al-Shirawi; Joseph E Parrillo; Peter Dodek; Stephen Lapinsky; Daniel Feinstein; Gordon Wood; Sandra Dial; Sergio Zanotti; Anand Kumar
Journal:  Hepatology       Date:  2012-12       Impact factor: 17.425

View more
  6 in total

1.  High yield, scalable and remotely drug-loaded neutrophil-derived extracellular vesicles (EVs) for anti-inflammation therapy.

Authors:  Jin Gao; Sihan Wang; Zhenjia Wang
Journal:  Biomaterials       Date:  2017-05-03       Impact factor: 12.479

2.  Significance of monitoring plasma concentration of voriconazole in a patient with liver failure: A case report.

Authors:  Xiaoyan Liu; Haibin Su; Jingjing Tong; Jing Chen; Haozhen Yang; Long Xiao; Jinhua Hu; Lina Zhang
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.889

3.  A Phase I trial using local regional treatment, nonlethal irradiation, intratumoral and systemic polyinosinic-polycytidylic acid polylysine carboxymethylcellulose to treat liver cancer: in search of the abscopal effect.

Authors:  Andrew N de la Torre; Sohail Contractor; Ismael Castaneda; Charles S Cathcart; Dolly Razdan; David Klyde; Piotr Kisza; Sharon F Gonzales; Andres M Salazar
Journal:  J Hepatocell Carcinoma       Date:  2017-08-07

4.  Thrombocytopenia on the first day of emergency department visit predicts higher risk of acute kidney injury among elderly patients.

Authors:  Chia-Ter Chao; Hung-Bin Tsai; Chih-Kang Chiang; Jenq-Wen Huang
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2017-02-10       Impact factor: 2.953

5.  Expression of peripheral monocytic programmed death ligand-1 in severe sepsis combined with HBV-related cirrhosis. A pilot observational study.

Authors:  Yi Lu; Guoxing Wang; Chunsheng Li
Journal:  Cent Eur J Immunol       Date:  2021-08-06       Impact factor: 2.085

Review 6.  Update on diagnosis and management of sepsis in cirrhosis: Current advances.

Authors:  Cyriac Abby Philips; Rizwan Ahamed; Sasidharan Rajesh; Tom George; Meera Mohanan; Philip Augustine
Journal:  World J Hepatol       Date:  2020-08-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.